TGFB1 and pulmonary fibrosis: Oral administration of EOCW alleviated the progression of pulmonary fibrosis in a bleomycin-induced mouse model, with a reduction in myofibroblast differentiation that may be attributed to the inhibition of TGF-β expression (Tavares et al., 2021)